|
ZDHHC17 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78294999999551E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.172700E-04 |
| Normal-vs-Stage2 |
3.5081000000492E-06 |
| Normal-vs-Stage3 |
3.64590000001552E-06 |
| Normal-vs-Stage4 |
5.77189999999561E-05 |
| Stage1-vs-Stage2 |
5.111900E-02 |
| Stage1-vs-Stage3 |
1.418400E-01 |
| Stage1-vs-Stage4 |
2.002000E-01 |
| Stage2-vs-Stage3 |
4.972400E-01 |
| Stage2-vs-Stage4 |
5.764400E-01 |
| Stage3-vs-Stage4 |
9.431400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.67510000000215E-05 |
| Normal-vs-AfricanAmerican |
3.362400E-02 |
| Normal-vs-Asian |
5.131700E-02 |
| Caucasian-vs-AfricanAmerican |
4.829400E-01 |
| Caucasian-vs-Asian |
1.319030E-01 |
| AfricanAmerican-vs-Asian |
6.930600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85896000000074E-05 |
| Normal-vs-Female |
5.52059999999743E-05 |
| Male-vs-Female |
6.323200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.563400E-04 |
| Normal-vs-Age(41-60Yrs) |
2.366300E-04 |
| Normal-vs-Age(61-80Yrs) |
4.40499999809774E-08 |
| Normal-vs-Age(81-100Yrs) |
6.243700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.034200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.815800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.756100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.745800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.091000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.380200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.573420E-01 |
| Classical-VS-Follicular |
9.995800E-03 |
| Classical-VS-Other |
9.124200E-01 |
| Classical-VS-Normal |
4.599300E-04 |
| Tall-VS-Follicular |
2.908400E-01 |
| Tall-VS-Other |
6.010200E-01 |
| Tall-VS-Normal |
2.396500E-04 |
| Follicular-VS-Other |
4.638000E-01 |
| Follicular-VS-Normal |
4.28990000000962E-06 |
| Other-VS-Normal |
1.475990E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.49410000219675E-08 |
| Normal-vs-N1 |
6.365700E-02 |
| N0-vs-N1 |
5.883000E-03 |
|
|
